{
  "created_at": "Fri Nov 12 17:4:51 +0000 2021",
  "id_str": "1459187253415137281",
  "full_text": "Two new antiviral drugs have been deemed so effective at fighting covid-19 that clinical trials ended early https://t.co/NQ9Ohs4ZGc",
  "display_text_range": [
    0,
    131
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/NQ9Ohs4ZGc",
        "expanded_url": "https://econ.st/3F9oYoB",
        "display_url": "econ.st/3F9oYoB",
        "indices": [
          108,
          131
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 32,
  "favorite_count": 91,
  "possibly_sensitive": false,
  "original_created_at": "Fri Nov 12 15:52:06 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "2つの新しい抗ウイルス剤がcovid-19に有効であると判断され、臨床試験が早期に終了した https://t.co/NQ9Ohs4ZGc"
    },
    {
      "locale": "zh",
      "full_text": "两种新的抗病毒药物被认为在对抗covid-19方面非常有效，临床试验提前结束https://t.co/NQ9Ohs4ZGc。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "兩種新的抗病毒藥物被認爲在對抗covid-19方面非常有效，臨牀試驗提前結束https://t.co/NQ9Ohs4ZGc。"
    }
  ]
}